vital glp 1 complete reviews Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions GLP-1 Weight-Loss Drug Demonstration Begins

The study included substantial preclinical work and a small proof-of-concept human component, so it should not be generalized to every older, frail, or medically complex patient

The effect of GLP-1 receptor agonists on anxiety: a systematic review

GLP-1 therapy is not a "quick fix," it's a steady, controlled metabolic change

Retatrutides Phase 3 TRIUMPH-4 trial, published in December 2025, showed participants on the 12mg dose lost an average of 28.7% of their body weight over 68 weeks, with nearly 40% of participants losing 30% or more

Semaglutide versus tirzepatide Tirzepatide represents the next evolution beyond semaglutide

2023, www.uptodate.com/contents/glucagon-like-peptide-1-based-therapies-for-the-treatment-of-type-2-diabetes-mellitus/print?search=tirzepatide&source=search_result&selectedTitle=1~5&usage_type=default&display_rank=1